Table 1

Logistic regression analysis of risk factors for interrupted evaluation

FactorsNumberIE (%)Crude OR (95% CI)Adjusted OR (95% CI)P value (Wald's test)P value (LR test)
All72551125 (16)
Age (years)<0.001
 0-14364 (11)1.18 (0.41 to 3.34)0.97 (0.33 to 2.8)0.952
 15-643558342 (10)Reference
 65+3661779 (21)2.54 (2.22 to 2.91)2.42 (2.1 to 2.8)<0.001
Sex0.817
 Female2158315 (15)Reference
 Male5097810 (16)1.11 (0.96 to 1.27)0.98 (0.85 to 1.14)0.817
Area<0.001
 Centre1332234 (18)Reference
 East41976 (18)1.04 (0.78 to 1.38)1.12 (0.83 to 1.51)0.458
 Kaohsiung City1507267 (18)1.01 (0.83 to 1.23)1.09 (0.89 to 1.33)0.419
 North74098 (13)0.72 (0.55 to 0.92)0.77 (0.59 to 1)0.054
 South1087179 (16)0.93 (0.75 to 1.15)0.95 (0.76 to 1.19)0.672
 Taipei City2170271 (12)0.67 (0.55 to 0.81)0.75 (0.62 to 0.92)0.005
Comorbidity
 CLD1192277 (23)1.86 (1.6 to 2.17)1.91 (1.62 to 2.24)<0.001<0.001
 DM1191136 (11)0.66 (0.55 to 0.8)0.64 (0.53 to 0.78)<0.001<0.001
 HIV304 (13)0.84 (0.29 to 2.4)1.52 (0.51 to 4.49)0.4510.472
Initial level<0.001
 A3104539 (17)Reference
 B1275203 (16)0.9 (0.76 to 1.08)0.78 (0.65 to 0.93)0.007
 C1644210 (13)0.7 (0.59 to 0.83)0.68 (0.57 to 0.82)<0.001
 D1232173 (14)0.78 (0.65 to 0.94)0.75 (0.62 to 0.92)0.005
Pathway overlaps 20032110493 (23)2.18 (1.91 to 2.48)2.32 (2.02 to 2.66)<0.001<0.001
  • Healthcare facility levels: A, for primary care/ general practice; B, for regional hospitals with inpatient capacity; C, for larger district hospitals; D, for large hospitals with a range of specialists.

  • Comorbidities and pathway overlaps 2003 are binary variables, applying 'none' as the reference groups.

  • Crude and adjusted ORs were calculated from the results of univariate and multivariate logistic regressions, respectively.

  • CLD, chronic lung disease; DM, diabetes mellitus; IE, interrupted evaluation; LR, likelihood ratio.